Adaptive Immunity
21 – 30 of 55
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Mycophenolate mofetil for systemic sclerosis : Drug exposure exhibits considerable inter-individual variation-a prospective, observational study
(
- Contribution to journal › Article
-
Mark
Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming of Region-Specific Immunity
(
- Contribution to journal › Article
-
Mark
Covalent Functionalization of Bioengineered Polyhydroxyalkanoate Spheres Directed by Specific Protein-Protein Interactions
(
- Contribution to journal › Article
- 2019
-
Mark
Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells
(
- Contribution to journal › Article
- 2018
-
Mark
AMPK activation by A-769662 and 991 does not affect catecholamine-induced lipolysis in human adipocytes
(
- Contribution to journal › Article
-
Mark
Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease
(
- Contribution to journal › Article
-
Mark
Molecular control of follicular helper T cell development and differentiation
(
- Contribution to journal › Scientific review
-
Mark
Intestinal CD103+CD11b+ cDC2 conventional dendritic cells are required for primary CD4+ T and B cell responses to soluble flagellin
(
- Contribution to journal › Article
-
Mark
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
(
- Contribution to journal › Article
-
Mark
CD103 + CD11b + mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin
(
- Contribution to journal › Article